Samrat Pharmachem has informed that it enclosed the Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2025, received from MUFG Intime India (RTA).
The above information is a part of company’s filings submitted to BSE.